It was demonstrated that GPER acts as a tumor suppressor in cancers that are not classically considered hormone responsive, suggesting that GPER activity may contribute to biological differences between the sexes that influence cancer progression and response to modern therapies29. Here, GPER1 is linked to neoplasm.